Failure of mitotic checkpoint machinery leads to the chromosomal missegregation and nuclear endoreduplication, thereby driving the emergence of aneuploidy and tetraploidy population. Although abnormal nuclear ploidy and the resulting impairment of mitotic checkpoint function are typical physiological event leading to human hepatocellular carcinoma, any mutational change of mitotic checkpoint regulators has not yet been discovered. Therefore, we investigated the mutation of p31 comet , a recently identified mitotic checkpoint regulator, in human hepatocellular carcinoma. Of 51 human hepatocellular carcinoma tissue and 6 cell lines tested, five samples exhibited nucleotide sequence variations dispersed on four sites within the entire coding sequence. Among these sites with sequence substitutions, three were found to be missense mutation accompanied with amino acid change but one was a silent mutation. Of these sequence substitutions, two were present in both tumor and non-tumor liver tissues, suggesting the possibility of polymorphism. The present findings indicate that p31 comet does not have an impact on the formation of aneuploidy and tetraploidy found in human hepatocellular carcinoma.
Introduction
Hepatocellular carcinoma (HCC) is one of the most common cancers in worldwide, with a high incidence in developing country (Parkin et al., 1999) . Hepatitis virus infection, alcohol consumption, and aflatoxin B1 are major factors for hepatocarcinogenesis (Hardell et al., 1984; Nishioka et al., 1991; Feitelson, 1999; Kops et al., 2004) . However, mechanism of hepatic carcinogenesis is not well known.
Aneuploidy, a phenotype associated with the loss or gain of chromosome number is a critical feature of many types of human cancers (Mitelman, 1983) . The defect of mitotic checkpoint plays a major role in inducing the chromosome instability and aneuploidy (Kops et al., 2005) . The mutations of mitotic checkpoint such as BubRI and Bub I has been identified in a variety of human cancers (Haruki et al., 2001; Saeki et al., 2002; Lee, 2003; Baker et al., 2004; Hanks et al., 2004) .
Mad2 is a key regulator of spindle checkpoint, by inducing mitosis arrest through the inhibition of APC complex (Fang et al., 1998; Luo et al., 2000) . However, recent reports studying the mutation or expression of Mad2 showed that its defect was not a key factor in inducing tumorigenesis of various types of human tumors. Mutation of human Mad2 gene is very rare in breast, liver, lung and bladder cancers (Takahashi et al., 1999; Gemma et al., 2001; Hernando et al., 2001) .
On the other hand, several papers reported an interesting result that argues against the above view of the nonessential role of Mad2 in tu- morigenesis. Michel and his colleagues observed that near complete depletion of Mad2 protein level by RNA interference induces mitotic failure and apoptosis in tumor and primary human somatic cells (Michel et al., 2004) . Inhibition of spindle checkpoint signaling by ablating Mad2 results in being invariably lethal as a consequence of massive chromosome loss (Kops et al., 2004) . These previous reports suggest that Mad2 depletion may play a major role in the suppression of tumorigenesis in many types of human tumors. In the present work, we analyzed the mutation and expression of p31 comet , a binding partner for Mad2 (Habu et al., 2002; Xia et al., 2004; Mapelli et al., 2006) , in primary human hepatocellular carcinoma tissues and cell lines.
Materials and Methods

Patients and tissue samples
Surgical specimens were obtained from 51 patients who underwent surgical treatment for HCC at Korea Institute of Radiological and Medical Sciences (KIRAMS). Informed consent was obtained from patients for the use of their operated specimens for research purpose. All tissues were surgically resected, immediately frozen and stored in liquid nitrogen until analyzed. Both tumor and adjacent non-tumor liver tissues were collected.
Cell culture and RNA preparation
Four different HCC cell lines, SNU354, SNU368, SNU387 and SNU475, were obtained from Korean Cell Line Bank (http://cellbank.snu.ac.kr/) (Park et al., 1995) . HepG2, Hep3B, SK-HEP-1 and PLC/ PRF/5 cell lines were purchased from ATCC (ATCC, Manassas, VA). These cell lines including Chang liver and Huh7 were cultured in DMEM supplemented with 10% FBS. Total RNA was extracted from the cultured cells and primary tissues using a RNA Isolation kit (QIAGEN) according to the protocol recommended by the manufacturer.
PCR-SSCP and automatic sequencing analysis
Each mRNA sample was examined for the presence of a mutation in the p31 comet gene by PCR-SSCP analysis. In brief, for reverse transcription, RNA mixture including 1 µg extracted total RNA and RNasin (Promega) was heated at 65 o C for 10 min, and then cooled on ice. Reverse transcription reaction was carried out in 20 µl of reverse transcription mixture containing 4 µl of reverse transcription buffer (Gibco BRL), 10 mM of dNTPs, 10 pmol Oligo (dT)15 primer, 10 mM DTT, 200 U M-MulV RTase reverse transcriptase (Gibco BRL) and 5 µl RNA mixture. After incubation at 37 o C for 60 min, PCR using reverse-transcribed cDNAs was performed by using 4 sets of oligonucleotide primers for p31 comet in the presence of [α-32 P]dCTP. Oligonucleotide primers used for PCR amplification are shown in Table 1 . Thirty-five cycles were used for each primers and consisted of 45 s denaturation at 95 o C, 45 s annealing at 56 o C, 1 min polymerization at 72 o C, and final 10 min extension at 72 o C. RT-PCR products were electrophoretically separated on 6% non-denaturing polyacrylamide gels in the presence of 5% glycerol at room temperature, and drying the gels, the gels were exposed to X-ray films at -80 o C overnight. The RT-PCR products of primary HCC specimens, and cell lines were subjected to automatic sequencing analysis.
Semi-quantitative RT-PCR
The RT procedure for semi-quantitation was conducted with the same method as described in RT-PCR-SSCP and automatic sequencing analysis. In brief, PCR was carried out for each gene using S1 and A1 primers (Table 1) for a 450-bp fragment of human p31 comet and 5'-atcatgtttgagaccttcaacacccc-3' (sense primer) and 5'-catctcttgctcgaagtccagggcga-3'(antisense primer) for a 317-bp fragment of human β-actin. To quantitate the expression level of p31 comet , β-actin was used as an internal control. The β-actin oligonucleotide primer was added to the same reaction tube and the PCR products were harvested at every two cycle intervals from cycle 28 to cycle 40. Each amplified sample was subjected to electrophoresis on a 2% agarose gel and visualized by staining with ethidium bromide.
Results
Mutation of p31 comet gene in human hepatocellular carcinoma
From 1.28 kb mRNA sequence data of human p31 comet (Habu et al., 2002) , we designed 4 primer sets to cover and overlap the entire coding region for the sequence analysis in human hepatocellular carcinoma (Table 1) . For cross-checking sequence abnormality and allelic variation, two analytical methods, PCR-SSCP and automatic nucleotide sequence were adopted for the present study. Of 51 human hepatocellular carcinoma specimens, we identified that four cases (7.8%) harbored sequence variations within the coding region of p31 comet ( Figure 1A ). At nucleotide 19 near Nterminal region, a G to A transversion was accompanied with amino acid change from valine to isoleucine (sample #; H49). PCR-SSCP analysis further supports that this substitution occurred only on one allele ( Figure 1A ). The second sequence variation at nucleotide sequence 226, located at 31 bp apart from Mad2 binding site (Habu et al., 2002) , was a C to G transversion changing an amino acid from leucine to valine (sample #; H9).
The third substitution was a G to T transversion located at nucleotide 602, changing an amino acid from serine to isoleucine. This type of substitution was shown in two patient specimens (sample #; H53 and H61). Of these mutations, the sequence variation at nucleotide 19 was found to be present only in tumor specimens but not in counterpart non-tumor liver tissues ( Figure 1A and 1B) . However, the other two sequence variations at nucleotide 226 and 602 were observed in both tumor and non-tumor liver tissues, suggesting the possibility of polymorphism on p31 comet coding region. In an analysis using liver cancer cell lines, Chang liver cell line exhibited the aberrant band shift (Figure 2A) , and a single nucleotide substitution without amino acid change at nucleotide position 720 ( Figure 2B ), indicating the silent mutation. The types of sequence variations of p31 comet found in hepatocellular carcinoma tissues and cell lines was summarized (Table 2) , three with amino acid substitution and one without amino acid change. The previous reports that Mad2 mutation frequency is extremely low (Takahashi et al., 1999; Gemma et al., 2001; Hernando et al., 2001) , together with our present findings illustrate a notion that a circuit of p31 comet and Mad2 may not contribute to the formation of aneuploidy and tetraploidy found in human hepatocellular carcinoma.
Transcriptional level of p31 comet in human hepatocellular carcinoma
Expression of human p31 comet gene varies during cell cycle progression in which the level transiently increases at mitosis phase (Habu et al., 2002) . Due to the relatively low frequency of p31 comet mutation, we attempted to examine the expressional level in hepatocellular carcinoma. In an expression analysis of 51 human hepatocellular carcinoma tissues by quantitative RT-PCR, the majority of them including samples with p31 comet mutation did not exhibit differences of p31 comet transcriptional level between tumor and non-tumor liver tissues ( Figure 3A and 3B) . The absence of the expression variation was further confirmed in 8 human liver cancer cell lines ( Figure 3C ). The present expression analysis suggests that p31 comet transcriptional level, itself, may not contribute to the formation of aneuploidy or teraploidy in human hepatocellular carcinoma.
Discussion
Disruption of genes participating in the regulation of mitotic checkpoint can lead to abnormal chromosome segregation, and then bear the aneuploid cells. Mad2 is one of the major components in the regulation of mitotic checkpoint. Dysfunction of Mad2 in tumor has been reported in a few paper, however its role in cancer development is unclear. Saeki and Tamura reported that about 65% of comet and β-actin band intensities were scanned and the relative p31 comet mRNA levels (ratios of the values of p31 comet mRNA/β-actin mRNA) of HCC tissues were compared with those of non-tumor liver tissues. The cut off value of the relative ratio for counting differential expression between HCC and corresponding non-tumor liver tissues was 2-folds, according to the previous quantitative analysis (Kim et al., 2004) . Ratios of tumor versus non-tumor are shown on top of the graph.
aneuploid HCC cell lines exhibited an impaired spindle checkpoint, but they could not find any mutation in mitotic checkpoint genes (Saeki et al., 2002) . These data suggest that mutations of other mitotic checkpoint regulator may contribute to induce tumorigenesis of liver. In the present study, we analyzed the mutation and expression of p31 comet , a mitotic checkpoint regulator counteracting Mad2 function. We performed mutation analysis of the p31 comet gene in 6 human hepatocellular carcinoma cell lines and 51 primary tumor tissues. Four different nucleotide substitutions were detected on the coding region of p31 comet (Table 2) . Of these four mutations, three were defined as a somatic missense mutation, a substitution accompanying with amino acid change and one was a silent mutation without amino acid change. Since two types of the somatic mutations were found in both tumor and non-tumor liver tissues, we can not exclude the possibility whether these mutations might be a polymorphism. p31 comet has a Mad2 binding region from 55 to 64 amino acids and is detected as a 34 kDa protein on SDS-PAGE gel (Habu et al., 2002) . Transient depletion of p31 comet by antisense oligonucleotide induces a minor apoptosis following a delay in the onset of anaphase in HeLa cells treated with nocodazole, a spindle poison agent (Habu et al., 2002) . Similar to the depletion of p31 comet , overexpression of p31 comet was found to induce strongly cell death of HCC cell lines without the treatment of nocodazole (unpublished data), indicating that the abnormal expression of p31 comet may drive the cells to the pathway for apoptosis induction. However, the mutation frequency of p31 comet in HCC tumor specimens was low and the transcriptional level was shown to be similar to their corresponding non-tumor liver tissues. In conclusion, as predicted from the results describing low level of mutation rate and expression variation of the p31 comet gene, p31 comet may not play a role in the pathogenesis of human liver cancer. We need further study for the analysis of p31 comet mutation and malfunction in other primary tumor
